Trinex (Triclabendazole)

No disponible

Categoría:

Otra

Marca comercial: Trinex
Componente activo: Triclabendazole
Para que se usa: Se utiliza para tratar las pulgas hepáticas, específicamente la fascioliasis y la paragonimiasis
Dosis disponible: 2mg

Información de entrega

Sin envíos a EE.UU.

* Los precios de la lista no se aplican a Suiza, Suecia y Dinamarca. Se sugiere a los clientes crear un pedido y luego nuestro equipo se comunicará con ellos para compartir los precios actuales.

Este producto fue visto por 30 usuarios

Envío gratis para los envíos superiores a €200
Paquete discreto. Seguro y confidencial
Devolución de dinero 100% garantizado
No se necesita la receta

Descripción

Triclabendazole, manufactured by Novartis pharmaceuticals, is an antihelminthic drug that was approved by the FDA in February 2019 for the treatment of fascioliasis in humans. Fascioliasis is a parasitic infection often caused by the helminth, Fasciola hepatica, which is also known as “the common liver fluke” or “the sheep liver fluke” or by Fasciola gigantica, another helminth. These parasites can infect humans following ingestion of larvae in contaminated water or food.

Triclabendazole was previously used in the treatment of fascioliasis in livestock, but is now approved for human use. This drug is currently the only FDA-approved drug for individuals with fascioliasis, which affects 2.4 million people worldwide

By Cathy Wong | Claudia Chaves Medically reviewed by

Updated on 21.11.2024

Compartir la opinión